Global Research Trends on the Link Between the Microbiome and COPD: A Bibliometric Analysis

References

• Raherison C, Girodet PO. Epidemiology of COPD. Eur Respir Rev. 2009;18(114):213–221. doi:10.1183/09059180.00003609
   PubMedGoogle Scholar
• Agustí A, Vogelmeier C, Faner R. COPD 2020: changes and challenges. Am J Physiol Lung Cell Mol Physiol. 2020;319(5):L879–L883. doi:10.1152/ajplung.00429
   Web of Science ®Google Scholar
• Rabe KF, Watz H. Chronic obstructive pulmonary disease. Lancet. 2017;389(10082):1931–1940. doi:10.1016/S0140-6736(17)31222-9
   PubMed Web of Science ®Google Scholar
• Polverino F, Sam A, Guerra S. COPD: to be or not to be, that is the question. Am J Med. 2019;132(11):1271–1278. doi:10.1016/j.amjmed.2019.04.047
   PubMed Web of Science ®Google Scholar
• Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–2128. doi:10.1016/S0140-6736(12)61728-0
   PubMed Web of Science ®Google Scholar
• GBD 2015 Chronic Respiratory Disease Collaborators. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017;2017(9):691–706. doi:10.1016/S2213-2600(17)30293-X
   Google Scholar
• Sin DD, Anthonisen NR, Soriano JB, et al. Mortality in COPD: role of comorbidities. Eur Respir J. 2006;28(6):1245–1257. doi:10.1183/09031936.00133805
   PubMed Web of Science ®Google Scholar
• Hilty M, Burke C, Pedro H, et al. Disordered microbial communities in asthmatic airways. PLoS One. 2010;5(1):e8578. doi:10.1371/journal.pone.0008578
   PubMed Web of Science ®Google Scholar
• Mammen MJ, Sethi S. COPD and the microbiome. Respirology. 2016;21(4):590–599. doi:10.1111/resp.12732
   PubMed Web of Science ®Google Scholar
• Gill SR, Pop M, Deboy RT, et al. Metagenomic analysis of the human distal gut microbiome. Science. 2006;312(5778):1355–1359. doi:10.1126/science.1124234
   PubMed Web of Science ®Google Scholar
• Chotirmall SH, Gellatly SL, Budden KF, et al. Microbiomes in respiratory health and disease: an Asia-Pacific perspective. Respirology. 2017;22(2):240–250. doi:10.1111/resp.12971
   PubMed Web of Science ®Google Scholar
• Tiew PY, Mac Aogain M, Ali NABM, et al. The mycobiome in health and disease: emerging concepts, methodologies and challenges. Mycopathologia. 2020;185(2):207–231. doi:10.1007/s11046-019-00413-z
   PubMed Web of Science ®Google Scholar
• Lai HC, Lin TL, Chen TW, et al. Gut microbiota modulates COPD pathogenesis: role of anti-inflammatory Parabacteroides goldsteinii lipopolysaccharide. Gut. 2022;71(2):309–321. doi:10.1136/gutjnl-2020-322599
   PubMed Web of Science ®Google Scholar
• Zhu K, Zhou S, Xu A, et al. Microbiota imbalance contributes to COPD deterioration by enhancing IL-17a production via miR-122 and miR-30a. Mol Ther Nucleic Acids. 2020;22:520–529. doi:10.1016/j.omtn.2020.09.017
   PubMedGoogle Scholar
• Chunxi L, Haiyue L, Yanxia L, et al. The gut microbiota and respiratory diseases: new evidence. J Immunol Res. 2020;2020:2340670. doi:10.1155/2020/2340670
   PubMed Web of Science ®Google Scholar
• Russo C, Colaianni V, Ielo G, et al. Impact of lung microbiota on COPD. Biomedicines. 2022;10(6):1337. doi:10.3390/biomedicines10061337
   PubMed Web of Science ®Google Scholar
• Leiten EO, Nielsen R, Wiker HG, et al. The airway microbiota and exacerbations of COPD. ERJ Open Res. 2020;6(3):00168–2020. doi:10.1183/23120541.00168-2020
   PubMedGoogle Scholar
• Moed HF. New developments in the use of citation analysis in research evaluation. Arch Immunol Ther Exp. 2009;57(1):13–18. doi:10.1007/s00005-009-0001-5
   PubMed Web of Science ®Google Scholar
• Wang C, Lv T, Deng X. Bibliometric and visualized analysis of China’s smart grid research 2008–2018. Front Res Metr Anal. 2020;5:551147. doi:10.3389/frma.2020.551147
   Google Scholar
• Chen C, Hu Z, Liu S, et al. Emerging trends in regenerative medicine: a scientometric analysis in CiteSpace. Expert Opin Biol Ther. 2012;12(5):593–608. doi:10.1517/14712598.2012.674507
   PubMed Web of Science ®Google Scholar
• Synnestvedt MB, Chen C, Holmes JH. CiteSpace II: visualization and knowledge discovery in bibliographic databases. AMIA Annu Symp Proc. 2005;2005:724–728.
   PubMedGoogle Scholar
• Gu D, Li T, Wang X, et al. Visualizing the intellectual structure and evolution of electronic health and telemedicine research. Int J Med Inform. 2019;130:103947. doi:10.1016/j.ijmedinf.2019.08.007
   Web of Science ®Google Scholar
• Leng Z, He X, Li H, et al. Olfactory ensheathing cell transplantation for spinal cord injury: an 18-year bibliometric analysis based on the Web of Science. Neural Regen Res. 2013;8(14):1286–1296. doi:10.3969/j.issn.1673-5374.2013.14.005
   Web of Science ®Google Scholar
• Shao H, Kim G, Li Q, Newman G. Web of science-based green infrastructure: a bibliometric analysis in CiteSpace. Land. 2021;10(7):711. doi:10.3390/land10070711
   Web of Science ®Google Scholar
• Wang N, Chen S, Zhang X, et al. Global research status and hot trends in stem cells therapy for Intervertebral disc degeneration: a bibliometric and clinical study analysis. Front Pharmacol. 2022;13:873177. doi:10.3389/fphar.2022.873177
   PubMed Web of Science ®Google Scholar
• Jiang B, Feng C, Li C, et al. A bibliometric and visualization analysis of glucocorticoid-induced osteoporosis research from 2012 to 2021. Front Endocrinol. 2022;13:961471. doi:10.3389/fendo.2022.961471
   PubMed Web of Science ®Google Scholar
• Wang S, Lin X, Guan Y, et al. Bibliometric and visual analysis of time-restricted eating. Front Nutr. 2022;9:979702. doi:10.3389/fnut.2022.979702
   Web of Science ®Google Scholar
• Ahmad T. Global research trends in MERS-CoV: a comprehensive bibliometric analysis from 2012 to 2021. Front Public Health. 2022;10:933333. doi:10.3389/fpubh.2022.933333
   Google Scholar
• Chen C, Dubin R, Kim MC. Emerging trends and new developments in regenerative medicine: a scientometric update (2000–2014). Expert Opin Biol Ther. 2014;14(9):1295–1317. doi:10.1517/14712598.2014.920813
   PubMed Web of Science ®Google Scholar
• Mayhew D, Devos N, Lambert C, et al. Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations. Thorax. 2018;73(5):422–430. doi:10.1136/thoraxjnl-2017-210408
   PubMed Web of Science ®Google Scholar
• Sze MA, Dimitriu PA, Hayashi S, et al. The lung tissue microbiome in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;185(10):1073–1080. doi:10.1164/rccm.201111-2075OC
   PubMed Web of Science ®Google Scholar
• Wang Z, Bafadhel M, Haldar K, et al. Lung microbiome dynamics in COPD exacerbations. Eur Respir J. 2016;47(4):1082–1092. doi:10.1183/13993003.01406-2015
   PubMed Web of Science ®Google Scholar
• Erb-Downward JR, Thompson DL, Han MK, et al. Analysis of the lung microbiome in the “healthy” smoker and in COPD. PLoS One. 2011;6(2):e16384. doi:10.1371/journal.pone.0016384
   PubMed Web of Science ®Google Scholar
• Huang YJ, Sethi S, Murphy T, et al. Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease. J Clin Microbiol. 2014;52(8):2813–2823. doi:10.1128/JCM.00035-14
   PubMed Web of Science ®Google Scholar
• Morris A, Beck JM, Schloss PD, et al. Comparison of the respiratory microbiome in healthy nonsmokers and smokers. Am J Respir Crit Care Med. 2013;187(10):1067–1075. doi:10.1164/rccm.201210-1913OC
   PubMed Web of Science ®Google Scholar
• Pragman AA, Kim HB, Reilly CS, et al. The lung microbiome in moderate and severe chronic obstructive pulmonary disease. PLoS One. 2012;7(10):e47305. doi:10.1371/journal.pone.0047305
   PubMed Web of Science ®Google Scholar
• Molyneaux PL, Mallia P, Cox MJ, et al. Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;188(10):1224–1231. doi:10.1164/rccm.201302-0341OC
   PubMed Web of Science ®Google Scholar
• Millares L, Ferrari R, Gallego M, et al. Bronchial microbiome of severe COPD patients colonised by Pseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis. 2014;33(7):1101–1111. doi:10.1007/s10096-013-2044-0
   PubMed Web of Science ®Google Scholar
• Charlson ES, Bittinger K, Haas AR, et al. Topographical continuity of bacterial populations in the healthy human respiratory tract. Am J Respir Crit Care Med. 2011;184(8):957–963. doi:10.1164/rccm.201104-0655OC
   PubMed Web of Science ®Google Scholar
• Vutcovici M, Bitton A, Ernst P, et al. Inflammatory bowel disease and risk of mortality in COPD. Eur Respir J. 2016;47(5):1357–1364. doi:10.1183/13993003.01945-2015
   Web of Science ®Google Scholar
• Bowerman KL, Rehman SF, Vaughan A, et al. Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease. Nat Commun. 2020;11(1):5886. doi:10.1038/s41467-020-19701-0
   PubMed Web of Science ®Google Scholar
• Mahooti M, Abdolalipour E, Salehzadeh A, et al. Immunomodulatory and prophylactic effects of Bifidobacterium bifidum probiotic strain on influenza infection in mice. World J Microbiol Biotechnol. 2019;35(6):91. doi:10.1007/s11274-019-2667-0
   PubMed Web of Science ®Google Scholar
• Vareille-Delarbre M, Miquel S, Garcin S, et al. Immunomodulatory Effects of Lactobacillus plantarum on Inflammatory Response Induced by Klebsiella pneumoniae. Infect Immun. 2019;87(11):e00570–19. doi:10.1128/IAI.00570-19
   PubMed Web of Science ®Google Scholar
• Myr A, Kh A, Ec B, et al. Lung microbiome composition and bronchial epithelial gene expression in patients with COPD versus healthy individuals: a bacterial 16S rRNA gene sequencing and host transcriptomic analysis. Lancet Microbe. 2021;(7):e300–e310. doi:10.1016/S2666-5247(21)00035-5
   Google Scholar
• Wang Z, Locantore N, Haldar K, et al. Inflammatory endotype-associated airway microbiome in chronic obstructive pulmonary disease clinical stability and exacerbations: a multicohort longitudinal analysis. Am J Respir Crit Care Med. 2021;203(12):1488–1502. doi:10.1164/rccm.202009-3448OC
   PubMed Web of Science ®Google Scholar
• Huang YJ, Boushey HA. The sputum microbiome in chronic obstructive pulmonary disease exacerbations. Ann Am Thorac Soc. 2015;12(Suppl 2):S176–80. doi:10.1513/AnnalsATS.201506-319AW
   PubMed Web of Science ®Google Scholar
• Yan Z, Chen B, Yang Y, et al. Multi-omics analyses of airway host-microbe interactions in chronic obstructive pulmonary disease identify potential therapeutic interventions. Nat Microbiol. 2022;7(9):1361–1375. doi:10.1038/s41564-022-01196-8
   PubMed Web of Science ®Google Scholar
• Tiew PY, Dicker AJ, Keir HR, et al. A high-risk airway mycobiome is associated with frequent exacerbation and mortality in COPD. Eur Respir J. 2021;57(3):2002050. doi:10.1183/13993003.02050-2020
   PubMed Web of Science ®Google Scholar
• Wang Z, Liu H, Wang F, et al. A refined view of airway microbiome in chronic obstructive pulmonary disease at species and strain-levels. Front Microbiol. 2020;11:1758. doi:10.3389/fmicb.2020.01758
   PubMed Web of Science ®Google Scholar
• Malvisi L, Yarraguntla A, Mortier MC, et al. Impact of bacterial strain acquisition in the lung of patients with COPD: the AERIS study. Infect Dis. 2022;54(11):784–793. doi:10.1080/23744235.2022.2092648
   PubMed Web of Science ®Google Scholar
• Qu L, Cheng Q, Wang Y, et al. COPD and gut-lung axis: how microbiota and host inflammasome influence COPD and related therapeutics. Front Microbiol. 2022;13:868086. doi:10.3389/fmicb.2022.868086
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2016;138(1):16–27. doi:10.1016/j.jaci.2016.05.011
   PubMed Web of Science ®Google Scholar
• Di Stefano A, Caramori G, Ricciardolo FL, et al. Cellular and molecular mechanisms in chronic obstructive pulmonary disease: an overview. Clin Exp Allergy. 2004;34(8):1156–1167. doi:10.1111/j.1365-2222.2004.02030.x
   PubMed Web of Science ®Google Scholar
• Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med. 2008;359(22):2355–2365. doi:10.1056/NEJMra0800353
   PubMed Web of Science ®Google Scholar
• Soler N, Ewig S, Torres A, et al. Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. Eur Respir J. 1999;14(5):1015–1022. doi:10.1183/09031936.99.14510159
   PubMed Web of Science ®Google Scholar
• Bresser P, Out TA, van Alphen L, et al. Airway inflammation in nonobstructive and obstructive chronic bronchitis with chronic haemophilus influenzae airway infection. Comparison with noninfected patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;162(3Pt1):947–952. doi:10.1164/ajrccm.162.3.9908103
   Google Scholar
• Banerjee D, Khair OA, Honeybourne D. Impact of sputum bacteria on airway inflammation and health status in clinical stable COPD. Eur Respir J. 2004;23(5):685–691. doi:10.1183/09031936.04.00056804
   PubMed Web of Science ®Google Scholar
• Fuke S, Betsuyaku T, Nasuhara Y, et al. Chemokines in bronchiolar epithelium in the development of chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2004;31(4):405–412. doi:10.1165/rcmb.2004-0131OC
   Web of Science ®Google Scholar
• Aaron SD, Angel JB, Lunau M, et al. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;163(2):349–355. doi:10.1164/ajrccm.163.2.2003122
   PubMed Web of Science ®Google Scholar
• Sethi S, Murphy TF. Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-The-art review. Clin Microbiol Rev. 2001;14(2):336–363. doi:10.1128/CMR.14.2.336-363.2001
   PubMed Web of Science ®Google Scholar
• Jacobs DM, Ochs-Balcom HM, Zhao J, et al. Lower airway bacterial colonization patterns and species-specific interactions in chronic obstructive pulmonary disease. J Clin Microbiol. 2018;56(10):e00330–18. doi:10.1128/JCM.00330-18
   Web of Science ®Google Scholar
• Sethi S, Maloney J, Grove L, et al. Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006;173(9):991–998. doi:10.1164/rccm.200509-1525OC
   PubMed Web of Science ®Google Scholar
• Chung KF. Inflammatory mediators in chronic obstructive pulmonary disease. Curr Drug Targets Inflamm Allergy. 2005;4(6):619–625. doi:10.2174/156801005774912806
   PubMedGoogle Scholar
• Zhang M, Li Q, Zhang XY, et al. Relevance of lower airway bacterial colonization, airway inflammation, and pulmonary function in the stable stage of chronic obstructive pulmonary disease. Eur J Clin Microbiol Infect Dis. 2010;29(12):1487–1493. doi:10.1007/s10096-010-1027-7
   PubMed Web of Science ®Google Scholar
• Sethi S, Evans N, Grant BJ, et al. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med. 2002;347(7):465–471. doi:10.1056/NEJMoa012561
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Espinosa C, Fernández-Laso E, et al. Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPD. Chest. 1999;116(1):40–46. doi:10.1378/chest.116.1.40
   PubMed Web of Science ®Google Scholar
• Garcha DS, Thurston SJ, Patel AR, et al. Changes in prevalence and load of airway bacteria using quantitative PCR in stable and exacerbated COPD. Thorax. 2012;67(12):1075–1080. doi:10.1136/thoraxjnl-2012-201924
   PubMed Web of Science ®Google Scholar
• Papi A, Bellettato CM, Braccioni F, et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med. 2006;173(10):1114–1121. doi:10.1164/rccm.200506-859OC
   PubMed Web of Science ®Google Scholar
• Finney LJ, Ritchie A, Pollard E, et al. Lower airway colonization and inflammatory response in COPD: a focus on Haemophilus influenzae. Int J Chron Obstruct Pulmon Dis. 2014;9:1119–1132. doi:10.2147/COPD.S54477
   PubMed Web of Science ®Google Scholar
• Marin A, Garcia-Aymerich J, Sauleda J, et al. Effect of bronchial colonisation on airway and systemic inflammation in stable COPD. COPD. 2012;9(2):121–130. doi:10.3109/15412555.2011.636407
   PubMedGoogle Scholar
• King PT. Pseudomonas aeruginosa cross-infection: is this important in bronchiectasis and COPD? Respirology. 2019;24(10):926–927. doi:10.1111/resp.13578
   Web of Science ®Google Scholar
• Martínez-García MÁ, Faner R, Oscullo G, et al. Risk factors and relation with mortality of a new acquisition and persistence of Pseudomonas aeruginosa in COPD patients. COPD. 2021;18(3):333–340. doi:10.1080/15412555.2021.1884214
   PubMedGoogle Scholar
• Gallego M, Pomares X, Espasa M, et al. Pseudomonas aeruginosa isolates in severe chronic obstructive pulmonary disease: characterization and risk factors. BMC Pulm Med. 2014;14:103. doi:10.1186/1471-2466-14-103
   PubMed Web of Science ®Google Scholar
• Martínez-Solano L, Macia MD, Fajardo A, et al. Chronic Pseudomonas aeruginosa infection in chronic obstructive pulmonary disease. Clin Infect Dis. 2008;47(12):1526–1533. doi:10.1086/593186
   PubMed Web of Science ®Google Scholar
• Rakhimova E, Wiehlmann L, Brauer AL, et al. Pseudomonas aeruginosa population biology in chronic obstructive pulmonary disease. J Infect Dis. 2009;200(12):1928–1935. doi:10.1086/648404
   Web of Science ®Google Scholar
• Schultz H, Weiss JP. The bactericidal/permeability-increasing protein (BPI) in infection and inflammatory disease. Clin Chim Acta. 2007;384(1–2):12–23. doi:10.1016/j.cca.2007.07.005
   PubMed Web of Science ®Google Scholar
• Nakamoto K, Watanabe M, Sada M, et al. Pseudomonas aeruginosa-derived flagellin stimulates IL-6 and IL-8 production in human bronchial epithelial cells: a potential mechanism for progression and exacerbation of COPD. Exp Lung Res. 2019;45(8):255–266. doi:10.1080/01902148.2019.1665147
   PubMed Web of Science ®Google Scholar
• Martinez-García MA, Rigau D, Barrecheguren M, et al. Long-term risk of mortality associated with isolation of Pseudomonas aeruginosa in COPD: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2022;17:371–382. doi:10.2147/COPD.S346294
   PubMed Web of Science ®Google Scholar
• González-Juarbe N, Gilley RP, Hinojosa CA, et al. Pore-forming toxins induce macrophage necroptosis during acute bacterial pneumonia. PLoS Pathog. 2015;11(12):e1005337. doi:10.1371/journal.ppat.1005337
   PubMed Web of Science ®Google Scholar
• Ahn D, Prince A. Participation of necroptosis in the host response to acute bacterial pneumonia. J Innate Immun. 2017;9(3):262–270. doi:10.1159/000455100
   PubMed Web of Science ®Google Scholar
• Huvenne W, Lanckacker EA, Krysko O, et al. Exacerbation of cigarette smoke-induced pulmonary inflammation by Staphylococcus aureus enterotoxin B in mice. Respir Res. 2011;12(1):69. doi:10.1186/1465-9921-12-69
   Google Scholar
• Budden KF, Shukla SD, Rehman SF, et al. Functional effects of the microbiota in chronic respiratory disease. Lancet Respir Med. 2019;7(10):907–920. doi:10.1016/S2213-2600(18)30510-1
   PubMed Web of Science ®Google Scholar
• Dickson RP, Erb-Downward JR, Freeman CM, et al. Spatial variation in the healthy human lung microbiome and the adapted island model of lung biogeography. Ann Am Thorac Soc. 2015;12(6):821–830. doi:10.1513/AnnalsATS.201501-029OC
   PubMed Web of Science ®Google Scholar
• Han MK, Agusti A, Calverley PM, et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med. 2010;182(5):598–604. doi:10.1164/rccm.200912-1843CC
   PubMed Web of Science ®Google Scholar
• Dicker AJ, Huang JTJ, Lonergan M, et al. The sputum microbiome, airway inflammation, and mortality in chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2021;147(1):158–167. doi:10.1016/j.jaci.2020.02.040
   PubMed Web of Science ®Google Scholar
• Millares L, Pascual S, Montón C, et al. Relationship between the respiratory microbiome and the severity of airflow limitation, history of exacerbations and circulating eosinophils in COPD patients. BMC Pulm Med. 2019;19(1):112. doi:10.1186/s12890-019-0867-x
   PubMed Web of Science ®Google Scholar
• Dickson RP, Erb-Downward JR, Martinez FJ, et al. The microbiome and the respiratory tract. Annu Rev Physiol. 2016;78:481–504. doi:10.1146/annurev-physiol-021115-105238
   PubMed Web of Science ®Google Scholar
• Segal LN, Clemente JC, Tsay JC, et al. Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype. Nat Microbiol. 2016;1:16031. doi:10.1038/nmicrobiol.2016.31
   PubMed Web of Science ®Google Scholar
• Segal LN, Clemente JC, Wu BG, et al. Randomised, double-blind, placebo-controlled trial with azithromycin selects for anti-inflammatory microbial metabolites in the emphysematous lung. Thorax. 2017;72(1):13–22. doi:10.1136/thoraxjnl-2016-208599
   PubMed Web of Science ®Google Scholar
• Yadava K, Pattaroni C, Sichelstiel AK, et al. Microbiota promotes chronic pulmonary inflammation by enhancing IL-17A and autoantibodies. Am J Respir Crit Care Med. 2016;193(9):975–987. doi:10.1164/rccm.201504-0779OC
   PubMed Web of Science ®Google Scholar
• Einarsson GG, Comer DM, McIlreavey L, et al. Community dynamics and the lower airway microbiota in stable chronic obstructive pulmonary disease, smokers and healthy non-smokers. Thorax. 2016;71(9):795–803. doi:10.1136/thoraxjnl-2015-207235
   PubMed Web of Science ®Google Scholar
• Wang Z, Singh R, Miller BE, et al. Sputum microbiome temporal variability and dysbiosis in chronic obstructive pulmonary disease exacerbations: an analysis of the COPDMAP study. Thorax. 2018;73(4):331–338. doi:10.1136/thoraxjnl-2017-210741
   PubMed Web of Science ®Google Scholar
• Wang Z, Yang Y, Yan Z, et al. Multi-omic meta-analysis identifies functional signatures of airway microbiome in chronic obstructive pulmonary disease. ISME J. 2020;14(11):2748–2765. doi:10.1038/s41396-020-0727-y
   Web of Science ®Google Scholar
• Kanter JE, Kramer F, Barnhart S, et al. Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1. Proc Natl Acad Sci U S A. 2012;109(12):E715–24. doi:10.1073/pnas.1111600109
   PubMed Web of Science ®Google Scholar
• Zhou BR, Zhang JA, Zhang Q, et al. Palmitic acid induces production of proinflammatory cytokines interleukin-6, interleukin-1β, and tumor necrosis factor-α via a NF-κB-dependent mechanism in HaCaT keratinocytes. Mediators Inflamm. 2013;2013:530429. doi:10.1155/2013/530429
   PubMed Web of Science ®Google Scholar
• Moshal KS, Sen U, Tyagi N, et al. Regulation of homocysteine-induced MMP-9 by ERK1/2 pathway. Am J Physiol Cell Physiol. 2006;290(3):C883–91. doi:10.1152/ajpcell.00359.2005
   Web of Science ®Google Scholar
• O’Hara AM, Shanahan F. The gut flora as a forgotten organ. EMBO Rep. 2006;7(7):688–693. doi:10.1038/sj.embor.7400731
   PubMed Web of Science ®Google Scholar
• Madan JC, Koestler DC, Stanton BA, et al. Serial analysis of the gut and respiratory microbiome in cystic fibrosis in infancy: interaction between intestinal and respiratory tracts and impact of nutritional exposures. mBio. 2012;3(4):e00251–12. doi:10.1128/mBio.00251-12
   PubMed Web of Science ®Google Scholar
• Rutten EPA, Lenaerts K, Buurman WA, et al. Disturbed intestinal integrity in patients with COPD: effects of activities of daily living. Chest. 2014;145(2):245–252. doi:10.1378/chest.13-0584
   PubMed Web of Science ®Google Scholar
• Keely S, Talley NJ, Hansbro PM. Pulmonary-intestinal cross-talk in mucosal inflammatory disease. Mucosal Immunol. 2012;5(1):7–18. doi:10.1038/mi.2011.55
   PubMed Web of Science ®Google Scholar
• Chakradhar S. A curious connection: teasing apart the link between gut microbes and lung disease. Nat Med. 2017;23(4):402–404. doi:10.1038/nm0417-402
   Web of Science ®Google Scholar
• Harris B, Morjaria SM, Littmann ER, et al. Gut microbiota predict pulmonary infiltrates after allogeneic hematopoietic cell transplantation. Am J Respir Crit Care Med. 2016;194(4):450–463. doi:10.1164/rccm.201507-1491OC
   PubMed Web of Science ®Google Scholar
• Schuijt TJ, Lankelma JM, Scicluna BP, et al. The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia. Gut. 2016;65(4):575–583. doi:10.1136/gutjnl-2015-309728
   PubMed Web of Science ®Google Scholar
• Budden KF, Gellatly SL, Wood DL, et al. Emerging pathogenic links between microbiota and the gut-lung axis. Nat Rev Microbiol. 2017;15(1):55–63. doi:10.1038/nrmicro.2016.142
   PubMed Web of Science ®Google Scholar
• Wang Y, Li N, Li Q, et al. Xuanbai Chengqi decoction ameliorates pulmonary inflammation via reshaping gut microbiota and rectifying Th17/Treg imbalance in a murine model of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2021;16:3317–3335. doi:10.2147/COPD.S337181
   PubMed Web of Science ®Google Scholar
• Donovan C, Liu G, Shen S, et al. The role of the microbiome and the NLRP3 inflammasome in the gut and lung. J Leukoc Biol. 2020;108(3):925–935. doi:10.1002/JLB.3MR0720-472RR
   PubMed Web of Science ®Google Scholar
• Pinkerton JW, Kim RY, Robertson AAB, et al. Inflammasomes in the lung. Mol Immunol. 2017;86:44–55. doi:10.1016/j.molimm.2017.01.014
   PubMed Web of Science ®Google Scholar
• Carbone C, Piro G, Di Noia V, et al. Lung and gut microbiota as potential hidden driver of immunotherapy efficacy in lung cancer. Mediators Inflamm. 2019;2019:7652014. doi:10.1155/2019/7652014
   PubMed Web of Science ®Google Scholar
• Wypych TP, Wickramasinghe LC, Marsland BJ. The influence of the microbiome on respiratory health. Nat Immunol. 2019;20(10):1279–1290. doi:10.1038/s41590-019-0451-9
   PubMed Web of Science ®Google Scholar
• Li N, Dai Z, Wang Z, et al. Gut microbiota dysbiosis contributes to the development of chronic obstructive pulmonary disease. Respir Res. 2021;22(1):274. doi:10.1186/s12931-021-01872-z
   PubMed Web of Science ®Google Scholar
• Raftery AL, Tsantikos E, Harris NL, et al. Links between inflammatory bowel disease and chronic obstructive pulmonary disease. Front Immunol. 2020;11:2144. doi:10.3389/fimmu.2020.02144
   PubMed Web of Science ®Google Scholar
• Trompette A, Gollwitzer ES, Yadava K, et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med. 2014;20(2):159–166. doi:10.1038/nm.3444
   PubMed Web of Science ®Google Scholar
• Thorburn AN, McKenzie CI, Shen S, et al. Evidence that asthma is a developmental origin disease influenced by maternal diet and bacterial metabolites. Nat Commun. 2015;6:7320. doi:10.1038/ncomms8320
   PubMed Web of Science ®Google Scholar
• Fagundes CT, Amaral FA, Vieira AT, et al. Transient TLR activation restores inflammatory response and ability to control pulmonary bacterial infection in germfree mice. J Immunol. 2012;188(3):1411–1420. doi:10.4049/jimmunol.1101682
   PubMed Web of Science ®Google Scholar
• Clarke TB. Early innate immunity to bacterial infection in the lung is regulated systemically by the commensal microbiota via nod-like receptor ligands. Infect Immun. 2014;82(11):4596–4606. doi:10.1128/IAI.02212-14
   PubMed Web of Science ®Google Scholar
• Vaughan A, Frazer ZA, Hansbro PM, et al. COPD and the gut-lung axis: the therapeutic potential of fibre. J Thorac Dis. 2019;11(Suppl 17):S2173–S2180. doi:10.21037/jtd.2019.10.40
   PubMed Web of Science ®Google Scholar
• Hussain K, Letley DP, Greenaway AB, et al. Helicobacter pylori-mediated protection from allergy is associated with IL-10-secreting peripheral blood regulatory T cells. Front Immunol. 2016;7:71. doi:10.3389/fimmu.2016.00071
   PubMed Web of Science ®Google Scholar
• Dang AT, Marsland BJ. Microbes, metabolites, and the gut-lung axis. Mucosal Immunol. 2019;12(4):843–850. doi:10.1038/s41385-019-0160-6
   PubMed Web of Science ®Google Scholar
• Felmlee MA, Morse BL, Morris ME. γ-hydroxybutyric acid: pharmacokinetics, pharmacodynamics, and toxicology. AAPS J. 2021;23(1):22. doi:10.1208/s12248-020-00543-z
   PubMed Web of Science ®Google Scholar
• Kent-Dennis C, Penner GB. Effects of a proinflammatory response on metabolic function of cultured, primary ruminal epithelial cells. J Dairy Sci. 2021;104(1):1002–1017. doi:10.3168/jds.2020-19092
   PubMed Web of Science ®Google Scholar
• Kotlyarov S. Role of short-chain fatty acids produced by gut microbiota in innate lung immunity and pathogenesis of the heterogeneous course of chronic obstructive pulmonary disease. Int J Mol Sci. 2022;23(9):4768. doi:10.3390/ijms23094768
   Web of Science ®Google Scholar
• Mao J, Li Y, Bian Q, et al. The Bufei Jianpi formula improves mucosal immune function by remodeling gut microbiota through the SCFAs/GPR43/NLRP3 pathway in chronic obstructive pulmonary disease rats. Int J Chron Obstruct Pulmon Dis. 2022;17:1285–1298. doi:10.2147/COPD.S359428
   PubMed Web of Science ®Google Scholar